中国远大集团有限责任公司简介CompanyProfileofChinaGrandEnterprises,Inc.中国远大集I才I有限责任公司（以下简称中国远大集I才l）成立于1993年，系股份制集团公司，总部位丁•北京亚运村远大屮心。作为一家经营管理型投资公司，中国远大集团主营业务涵盖医药健康、置业投资、贸易产业及金融服务等产业领域。ChinaGrandEnterprises,Inc・（hereinafterreferredtoasCGE）,establishedin1993,isajoint-stockgroupcompany,headquarteredinGrandPlace,BeijingAsianGamesVillage.Asaninvestmentcompanyengagedinoperationandmanagement,CGE'scorebusinessescoverpharmaceuticalsandhealthcare,propertyinvestment,commercialtradebusiness,financialservicesandotherindustries.1、医药健康产业在医药健康产业领域，屮国远大集团已形成以华东医药股份冇限公司为龙头企业的发酵技术产业发展平台，以远大医约（中国）有限公司为龙头企业的化学合成药产业发展平台，以拥冇近三百年历史的雷允上药业集团公司为龙头企业的现代屮药产业发展平台，以远大蜀阳药业为龙头金业的血液制品、生物疫苗及生物制药产业发展平台；提供化学制剂、中药制剂、以血液制品及疫苗为基础的生物制剂等三大类近千品种的成药制剂品种；生产多种大宗原料药和當体激素类、肾上腺素类等多种特色原料药、糟细化工中间体和保健品等多个类别的医药相关产品；已形成各专业领域的营销体系，多项产品通过欧洲COS认证和美国FDA认证。中国远大集团一直将医药新产品研发作为战略重点，持续投入专项资金，通过构建自主研发平台，产学研相结合和国际合作等多种方式，不断成功开发出新产甜投放市场；已经形成了集产品研发、生产、销售于一体，屮西药并举，国际和国内市场共同发展的医•药健康产业模式。1.PharmaceuticalsandHealthcareIndustry---本文来源于网络，仅供参考，勿照抄，如有侵权请联系删除---Inthefieldofpharmaceuticalsandhealthcareindustry,CGEhasestablishedseveralcoreindustrialplatformswithinhercontrolledsubsidiarycompanies.TheseincludeHuadongPharmaceuticalCo.Ltd.thatplaysaleadingroleinfermentation-basedpharmaceuticalproduction,GrandPharma(China)Co.Ltd.aleaderinsyntheticchemistry-basedpharmaceuticalproduction,LeiYunshangPharmaceuticalGroupwithanearly300-yearhistoryoperatingintheproductionofmodernTraditionalChineseMedicine,andGrandShuyangPharmaceuticalCo.,Ltd.focusingontheproductionofbloodproducts,vaccinesandotherbiopharmaceuticalproducts.CGEpharmaceuticalandhealthcareindustryproducesnearlyathousandpharmaceuticalproductswhichbelongtothreemajorcategoriesincludingsyntheticchemicaldrugs,traditionalChinesemedicinesandbiopharmaceuticalsconsistingmainlyofbloodproductsandvaccines.AmongtheproductsofCGEpharmaceuticalandhealthcareindustryareincludedvariousbulkactivepharmaceuticalingredients(APIs),steroidhormones,adrenalinesandavarietyofotherspecialtyAPIs,finechemicalsandchemicalintermediates,healthcareproductsandvariousotherclassesofpharmaceuticalrelatedproducts.CGEpharmaceuticalandhealthcareindustryhasestablishedmarketingsystemsinvariousspecificfields,andmanyproductshavepassedEuropeanCOScertificationsandUSFDAinspections.CGEviewsherpharmaceuticalR&Dashavingstrategicimportanceandcontinuestoinvestalargeamountoffundsinspecificareas・Multipleapproachesthroughthebuild-upofinternalR&Dcapacity,establishingallianceswithacademicinstitutionsandinternationalcollaborationshaveresultedinthesuccessfuldevelopmentandlaunchofmanynewproductsinrecentyears.CGEhasbuiltacomprehensivebusinessmodelinherpharmaceuticalsandhealthcareindustrythatintegratesR&D,productionandmarketinganddistributionintoonewithacombinationoftraditionalChineseandWesternmedicines,andd...